Top-News

Charles River Laboratories International Aktie News

Aktie
WKN:  939391 ISIN:  US1598641074 US-Symbol:  CRL Land:  USA
184,04 $
+0,00 $
0,00%
157,92 € 01:00:00 Uhr
Depot/Watchlist
Marktkapitalisierung *
7,38 Mrd. €
Streubesitz
-
KGV
923
neu: Nachhaltigkeits-Score
49 %
Index-Zuordnung
S&P 500
Weiter aufwärts? Long handeln - Jetzt mit Hebel 7,21: MM8D55
Werbung

Charles River Laboratories International News

01.12.25 - PR Newswire
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS PR ...
01.12.25 - Businesswire
Charles River Laboratories to Present at Evercore Healthcare Conference
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Evercore 8 th Annual Healthcare Conference on Wednesday, December 3 rd , at ...
17.11.25 - Businesswire
Charles River Laboratories to Present at Jefferies Global Healthcare Conference
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Jefferies Global Healthcare Conference in London on Tuesday, November 18 th ...
07.11.25 - PR Newswire
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River ...
05.11.25 - Businesswire
Charles River Laboratories Provides Update on Strategic Review
Charles River Laboratories International, Inc. (NYSE: CRL) today announced an update on its Board of Directors’ comprehensive strategic review of the Company’s business and ...
05.11.25 - Businesswire
Charles River Laboratories Announces Third-Quarter 2025 Results
Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2025. For the quarter, revenue was $1.00 billion, a decrease of 0.5% from ...
27.10.25 - PR Newswire
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS PR ...
14.10.25 - Businesswire
Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release third-​quarter 2025 financial results on Wednesday, November 5 th , before the market opens. A conference ...
16.09.25 - Businesswire
Charles River Laboratories Announces Chief Financial Officer Transition
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that Flavia H. Pease, Corporate Executive Vice President and Chief Financial Officer (CFO), has ...
08.09.25 - Businesswire
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at two upcoming investor conferences, including:
30.07.25 - wallstreetONLINE Redaktion
Aktienanalyse: Evotec-Aktie: Ist sie nach über 83 % Kursrückgang jetzt ein Kauf?
Evotec kämpft mit Millionenverlusten. Wie realistisch ist ein Comeback?Evotec-​Aktien haben seit 2021 mehr als 83 Prozent an Wert verloren (28.07.2025). Ist das Geschäftsmodell ...

Newssuche

Videos

newspaper
02.12.25 +8,18%
Technical Trading: DAX Long dienstags
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »